Andreas Gschwind
- Immunology and Allergy top 2%
- Oncology top 2%
- HER2/EGFR in Cancer Research 7
- Cytokine Signaling Pathways and Interactions 2
- Molecular Biology top 5%
- Receptor Mechanisms and Signaling 2
- PI3K/AKT/mTOR signaling in cancer 2
- Protein Kinase Regulation and GTPase Signaling 1
- Chemical Synthesis and Analysis 1
- Cancer Research top 5%
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Estrogen and related hormone effects 2
- Co-authors
- Axel UllrichOliver M. FischerNorbert PrenzelStefan HartBeatrix SchäferMichael LesererA. UllrichEsther Zwick
- Partner nations
- GermanyUnited KingdomUnited States
In The Last Decade
Andreas Gschwind
10 papers receiving 2.6k citations
Hit Papers
Peers
Comparison fields: 5 of 101
- Immunology and Allergy 277
- Oncology 1.1k
- Molecular Biology 1.6k
- Cancer Research 311
- Radiology, Nuclear Medicine and Imaging 383
Countries citing papers authored by Andreas Gschwind
This map shows the geographic impact of Andreas Gschwind's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Gschwind with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Gschwind more than expected).
Fields of papers citing papers by Andreas Gschwind
This network shows the impact of papers produced by Andreas Gschwind. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Gschwind. The network helps show where Andreas Gschwind may publish in the future.
Co-authorship network
The 9 scholars most cited alongside Andreas Gschwind, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The discovery of receptor tyrosine kinases: targets for cancer therapybreakdown → | 2004 | 930 |
| 2 | 2004 | 137 | |
| 3 | 2004 | 127 | |
| 4 | Cell surface growth factor receptor molecules as targets for cancer therapy. | 2004 | 5 |
| 5 | 2003 | 281 | |
| 6 | 2003 | 221 | |
| 7 | 2003 | 329 | |
| 8 | Lysophosphatidic acid-induced squamous cell carcinoma cell proliferation and motility involves epidermal growth factor receptor signal transactivation. | 2002 | 182 |
| 9 | 2001 | 387 | |
| 10 | 2000 | 62 |
About Andreas Gschwind
Andreas Gschwind is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Immunology and Allergy, Molecular Biology and Genetics, having authored 10 papers that have together received 2.7k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (7 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Estrogen and related hormone effects (2 papers), Receptor Mechanisms and Signaling (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Cytokine Signaling Pathways and Interactions (2 papers), Protein Kinase Regulation and GTPase Signaling (1 paper) and Chemical Synthesis and Analysis (1 paper). The work is most often cited by research in Immunology and Allergy (277 citations), Oncology (1.1k citations), Molecular Biology (1.6k citations), Cancer Research (311 citations) and Radiology, Nuclear Medicine and Imaging (383 citations). Andreas Gschwind has collaborated with scholars based in Germany, United Kingdom and United States. Frequent co-authors include Axel Ullrich, Oliver M. Fischer, Norbert Prenzel, Stefan Hart, Beatrix Schäfer, Michael Leserer, A. Ullrich, Esther Zwick and Axel Ullrich. Their work appears in journals such as Oncogene, Nature reviews. Cancer, IUBMB Life, The EMBO Journal and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.